[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.98.119. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 1972

Clinical Efficacy Studies of Haloprogin, a New Topical Antimicrobial Agent

Author Affiliations

Evansville, Ind

From Medical Research Department, Mead Johnson and Co., Evansville, Ind.

Arch Dermatol. 1972;106(6):839-842. doi:10.1001/archderm.1972.01620150025009
Abstract

One percent haloprogin cream, a topical agent for the treatment of dermatophytoses, has proved efficacious in experimentally induced and naturally occurring human infections. These studies indicate haloprogin cream to be significantly (P<.05) more effective than placebo treatment. Efficacy was confirmed by a high percentage of clinical improvement, KOH reversals, and negative cultures. Simultaneously, by double-blind paired comparison and parallel studies, as well as open studies, 12 of these same investigators showed significantly (P<.05) greater efficacy of 1% haloprogin solution over placebo. Both haloprogin formulations were comparable to tolnaftate in the therapy of dermatophytoses.

×